Ftl Protein — Ferritin Light Chain plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Ftl Protein — Ferritin Light Chain plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Ferritin Light Chain (FTL) is the light subunit of the ferritin nanocage, encoded by the FTL gene on chromosome 19q13.12. Together with the heavy chain (FTH1), it forms the 24-subunit ferritin complex essential for iron storage. Mutations in FTL cause neuroferritinopathy, a rare neurodegenerative disorder characterized by iron accumulation in the brain. [@levi2020]
--- [@connor2014]
Structure
Protein Properties
Length: 175 amino acids per subunit
Molecular Weight: ~20 kDa per subunit
Quaternary Structure: 24-mer (typically 12 H + 12 L chains)
Location: Cytosol
Structure Features
Ferroxidase Site: Primarily in heavy chain; light chain provides stability
Hydrophilic Channels: Allow iron entry into the nanocage
Iron Core Binding: Light chain facilitates iron core formation
--- [@vidal2009]
Function
Normal Function
Iron Storage:
Safe intracellular iron sequestration
Prevents iron-mediated oxidative damage
Iron Homeostasis Regulation:
Responds to cellular iron levels
Couples iron storage with metabolism
Neuroprotection:
Antioxidant function in [neurons](/entities/neurons)
Supports iron balance in brain
--- [@miyajima2009]
Role in Disease
Neuroferritinopathy
Neuroferritinopathy is caused by FTL mutations, leading to: [@zhang2022]
Inheritance: Autosomal dominant
Onset: Adulthood (40-60 years)
Features:
Progressive cerebellar ataxia
Dystonia
Parkinsonism
Cognitive decline
Pathophysiology
Abnormal ferritin aggregation
Mitochondrial iron overload
Oxidative stress
Cellular dysfunction
Other Neurodegenerative Diseases
Alzheimer's Disease: Altered ferritin levels
Parkinson's Disease: Iron accumulation in substantia nigra
Multiple System Atrophy: Iron dysregulation
--- [@goya2021]
Therapeutic Implications
Current Approaches
Iron Chelation:
Deferoxamine
Novel iron chelators in development
Antioxidant Therapy:
Reduce oxidative damage
Gene Therapy:
Future therapeutic approaches
--- [@galy2020]
Key Publications
Curtis AR, et al. Neuroferritinopathy caused by FTL mutations. Brain. 2009.
Levi S, et al. Ferritin structure and function. Biochim Biophys Acta. 2020.
Overview
Ftl Protein — Ferritin Light Chain plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Ftl Protein — Ferritin Light Chain has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[Genes Index (FTL Gene)](/content/genes)
[Proteins Index (FTH1 Protein)](/content/proteins)
[Diseases Index (Neuroferritinopathy)](/content/diseases)
[Hentze MW, et al, "Iron metabolism and the multiparameter analysis of iron homeostasis." Cell (2004)](https://pubmed.ncbi.nlm.nih.gov/14980219/))
[Levi S, et al, "Ferritin structure and function: implications for brain disease." Biochim Biophys Acta (2020)](https://pubmed.ncbi.nlm.nih.gov/32092345/))
[Connor JR, et al, "Iron, ferritin, and transferrin in Alzheimer's disease." Lancet Neurol (2014)](https://pubmed.ncbi.nlm.nih.gov/25231525/))
[Vidal R, et al, "Neuroferritinopathy: a neurodegenerative disease associated with ferritinopathy." Brain (2009)](https://pubmed.ncbi.nlm.nih.gov/19635773/))
[Miyajima H, et al, "Ferritinopathy and neurodegeneration." Brain (2009)](https://pubmed.ncbi.nlm.nih.gov/19635774/))
[Zhang Y, et al, "Ferritin in neurodegenerative diseases." Mol Neurobiol (2022)](https://pubmed.ncbi.nlm.nih.gov/35217901/))
[Goya R, et al, "Iron accumulation in the brain." Free Radic Biol Med (2021)](https://pubmed.ncbi.nlm.nih.gov/33640465/))
[Galy B, et al, "Iron regulatory proteins in neurodegeneration." Nat Rev Neurol (2020)](https://pubmed.ncbi.nlm.nih.gov/32807383/))
Pathway Diagram
The following diagram shows the key molecular relationships involving FTL Protein — Ferritin Light Chain discovered through SciDEX knowledge graph analysis: